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Abstract
Health planners from global to local levels must anticipate year-to-year and week-
to-week variation in seasonal influenza activity when planning for and responding 
to epidemics to mitigate their impact. To help with this, countries routinely collect 
incidence of mild and severe respiratory illness and virologic data on circulating sub-
types and use these data for situational awareness, burden of disease estimates and 
severity assessments. Advanced analytics and modelling are increasingly used to aid 
planning and response activities by describing key features of influenza activity for 
a given location and generating forecasts that can be translated to useful actions 
such as enhanced risk communications, and informing clinical supply chains. Here, 
we describe the formation of the Influenza Incidence Analytics Group (IIAG), a coor-
dinated global effort to apply advanced analytics and modelling to public influenza 
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Influenza infection causes substantial morbidity and mortality 
every year in populations worldwide,1 and occasional pandem-
ics have the potential to cause far greater health impacts.2 The 
primary data sources used to track influenza are public health 
surveillance systems that report clinical visits for influenza-like 
syndromes (including influenza-like illness (ILI), acute respiratory 
infections (ARI) and severe acute respiratory infections (SARI)) 
during a given week and the numbers of positive virological tests 
for specific types and subtypes.3 Globally, the World Health 
Organization (WHO) curates two large public databases of syn-
dromic case counts (FluID,4 since 2009) and virologically con-
firmed influenza infection (Flunet,5 since 1997), with timely and 
robust data for many countries (Figure 1).
Health planners must anticipate year-to-year and week-to-week 
variation in influenza activity when planning for and responding to 
pandemics or seasonal epidemics. For example, advanced analytics 
and modelling have been used to help inform pandemic planning6-8 
and response.9-11 Also, retrospective analyses using data from sur-
veillance systems and other studies have illuminated important 
features about the transmission dynamics of influenza, including 
the characterization of spatial incidence patterns,12,13 planning for 
the optimal use of seasonal vaccines,14 early analyses of household 
transmission15 and global spatial spread.16
In addition, since the 2009 pandemic,17 quantitative models have 
been used to forecast seasonal influenza activity in real time. The 
field has grown rapidly18 from early retrospective studies19 to a large 
network of groups prospectively forecasting US influenza activity 
each year as part of a competition run by the US Centers for Disease 
Control and Prevention (CDC) to forecast the time of season onset, 
time of peak, intensity of peak and near-term incidence.20 A number 
of different techniques are used in the competition including crowd-
sourced expert judgement forecasts,21,22 mechanistic models,19 ma-
chine learning23 and statistical models.24 Also, different approaches 
can be combined into a single ensemble.25
However, despite this success in translating influenza surveil-
lance data into actionable forecasts and a number of forecasting 
studies from other locations (eg Refs26,27), there are currently no 
real-time efforts to apply advanced analytics to influenza data 
at a global scale. Also, most public health agencies do not have 
resident expertise in advanced analytics such as infectious dis-
ease forecasting, nor the expertise to interpret those results. 
Accessing analytical capacity from within this group represents a 
resource for public health agencies. Generating actionable results 
from advanced analytics at local and global scales could provide 
unique insights for managing the consequences of seasonal and 
pandemic influenza.
Here, we describe the formation of the Influenza Incidence 
Analytics Group (IIAG), an informal WHO coordinated global effort 
to apply advanced analytics and modelling to these data in real-time 
and thus provide additional insights to WHO Member States who re-
port the data to WHO. The WHO IIAG network includes academics 
and public health officials from national, regional and global orga-
nizations. We organise regular open conference calls and maintain 
a repository with up-to-date global incidence data, accompanying 
housekeeping code, and initial analytical tools.
Our objective is to systematically couple data to analytical tools 
to improve the data and analytical capabilities where possible and, 
most importantly, to increase the quality of actionable real-time 
influenza information available to public health institutions and or-
ganizations worldwide. With strong movements for both open data 
and open scientific code, we aim to gather both initiatives together 
to help create a community of investigators, developers and con-
sumers of analysis.
The WHO IIAG teleconference calls have provided a forum for 
the exchange of ideas, identifying challenges and potential solutions 
between WHO staff, country public health practitioners and aca-
demic groups working on the advanced analytics and modelling of 
influenza. WHO staff and country representatives have presented 
current data and outlined specific questions of interest. In response, 
analytical and modelling groups have presented related works in 
progress and model-derived forecasts based on the available WHO 
data. The frequent structured interactions between these commu-
nities have led to greater awareness and use of advanced analytics 
and modelling among public health experts, and greater under-
standing among the academic analytical community of public health 
challenges.
data, both epidemiological and virologic, in real-time and thus provide additional in-
sights to countries who provide routine surveillance data to WHO. Our objectives are 
to systematically increase the value of data to health planners by applying advanced 
analytics and forecasting and for results to be immediately reproducible and deploy-
able using an open repository of data and code. We expect the resources we develop 
and the associated community to provide an attractive option for the open analysis 
of key epidemiological data during seasonal epidemics and the early stages of an in-
fluenza pandemic.
K E Y W O R D S
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Analyses are presented and discussed. WHO staff report global 
patterns of incidence and issues emerging from different Members 
States, such as lower-than- or higher-than-expected incidence for 
the time of year or unusual age patterns in reported cases. Individual 
countries can then present their own data and analyses; examples 
have included forecasting results from England and Wales, the 
United States (Figure 2A) and Australia (Figure 2B). We also have 
global analyses that have been undertaken using mechanistic models 
and publicly available WHO data (Figure 2C, Ref28).
The global data sets and accompanying example code are avail-
able as publicly available repositories29,30 (Figure 1). The data are 
updated weekly, and the accompanying functions allow the rapid 
extraction of country-level incidence time series for both ILI and vi-
rologically confirmed influenza.
While the initiative is new and seems productive, we have 
faced a number of challenges thus far. Firstly, data quality is not 
consistent among the reporting countries nor geographically rep-
resentative. Timing, completeness and frequency of data reporting 
are not always optimal to allow forecasting. While the number of 
countries reporting data to FluNet (136 in 2016) and FluID (108 in 
2016) has increased substantially over the years, there is still room 
for improvement.
In addition, any changes to internal reporting, participating sites, 
case definitions, etc, may not be apparent. Therefore, the interpre-
tation of these data often requires some knowledge of the local 
context and thus input from local epidemiologists and public health 
professionals. Since these issues add an additional layer of complex-
ity to real-time forecasting, we have chosen not to launch a formal 
F I G U R E  1   Influenza-like-illness (ILI) 
data from the FluID database. Weekly 
scaled rates of ILI since 2010 for all 
countries that have reported for at least 
50% of weeks, from FluID database. 
For each country, ILI was rescaled by 
removing the mean and dividing by the 
variance. Colours represent the intensity 
of ILI activity from low (yellow) to high 
(red). Colours are based on the percentile 
of the distribution of scaled ILI (see 
above colour bar for values), with white 
representing lack of reporting. This plot 
can be reproduced by evaluating the R 
script “launch_figure.r” in the directory 
“notes” in the group code repository.30
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forecasting challenge at this time. We seek to augment data quality 
by working closely with countries to encourage frequent data up-
dates and demonstrate the utility of collecting and reporting data 
which could then enable a formal forecasting exercise. Such an ex-
ercise, if successful, could provide further advocacy for data quality 
improvement efforts.
Current efforts are only possible because of the large community 
of analytical scientists who are independently supported to study 
influenza independent of IIAG. However, we are acutely aware we 
are not exploiting the full value of these data and that our current 
momentum likely cannot be sustained without dedicated support for 
forecasting groups and organizing capacity. Promisingly however, 
the WHO meeting on Using Influenza Data for Severity Assessment 
(November 2018) brought together country representatives, the 
Pandemic Influenza Special Studies working group and IIAG to dis-
cuss how to better integrate analytical tools developed for analysis of 
seasonal influenza with pandemic influenza assessment. The contin-
ued communication and trust building between these groups during 
seasonal epidemics will be critical in the realization of the benefits 
of advanced analytics and modelling to inform decision-making in 
the next pandemic. This network would benefit greatly from modest 
central resources as previously demonstrated for prior networks of 
analytical scientists.31,32
The early stages of an influenza pandemic are a special case 
of an infectious disease outbreak:33,34 an outbreak which is more 
likely to occur than other pathogen types and which is also rela-
tively likely to result in a large epidemic. Many national influenza 
pandemic plans (eg United States, UK, Australia, Japan) articulate 
enhanced data collection protocols, the use of routine surveillance 
systems for non-routine purposes, and similar, to assess pathogen 
characteristics such as transmissibility and severity in the early 
stages of the pandemic. We would expect our activities and re-
sources to continue in the event of an influenza pandemic. We 
would hope to provide an attractive option for the open analysis 
of key epidemiological data during the first few weeks. Developing 
these collaborative working groups during “peacetime” (ie not in 
the early stages of a real pandemic) is critical to improving the 
ways in which advanced modelling is integrated into public health 
F I G U R E  2   Examples of influenza forecasting results for the United States (A), Australia (B) and Europe (C). A, Forecast made for week 
49, 2018 for national percentage of outpatient visits in the United States that would be for influenza-like illness for the following 4 wks. 
Based on results from multiple groups.25 B, Forecasts of the number of laboratory-confirmed influenza cases in Melbourne made on 2nd 
September 2018 (blue), with pre-season “prior” forecast based also on data from previous seasons (brown, made 8th July 2018)35 (C) 
Real-time forecast accuracy for 36 European countries during the 2017-18 influenza season.28 Plots show the proportion of forecasts that 
accurately predicted peak timing within 1 week of the observed value (red) and that accurately predicted peak intensity within 25% of 
the observed value (blue). The x-axis represents the number of weeks between the week of a forecast and the predicted peak week, with 
positive numbers indicating that the peak is predicted to have passed. The size of the points represents the number of forecasts produced 
at a given predicted lead week. Dashed lines show the comparative forecast accuracy when the forecasts are run retrospectively using the 
data available at the end of the season
     |  5BIGGERSTAFF ET Al.
decision-making. We articulate a strategic vision and provide a 
prototype technical implementation for bringing together global 
expertise on infectious disease surveillance and real-time model-
ling. These efforts provide an important template for informing 
and supporting public health efforts to combat global outbreaks 
of infectious disease.
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